Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
CA 2487566 C · Owner: Sauve, Anthony A. · Inventors: Sauve, Anthony A.; Schramm, Vern L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds having the formula: (I); Also provided are pro-drug compounds of the formula: (II); The invention also provides pharmaceutical compositions containing the above compounds methods , of using the above compounds as pharmaceuticals and processes for preparing , the above compounds. Methods for inhibiting an ADP-ribosyl transferase ADP-, ribosyl cyclase, ADP-ribosyl hydrolase or NAD-dependent deacetylase enzyme , using the above compounds and methods for treating a disease or condition associated with an ADP-ribosyl transferase ADP- 'ribosyl cyclase, ADP-ribosyl , hydrolase or NAD-dependent deacetylase enzyme in a subject using the above compounds …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 30, 2003 and granted August 7, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.